These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23844047)

  • 1. BOLD fMRI in the white matter as a marker of aging and small vessel disease.
    Makedonov I; Black SE; Macintosh BJ
    PLoS One; 2013; 8(7):e67652. PubMed ID: 23844047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White Matter Cerebrovascular Reactivity: Effects of Microangiopathy and Proximal Occlusions on the Dynamic BOLD Response.
    Gee JM; Wang X; Dogra S; Veraart J; Ishida K; Dehkharghani S
    medRxiv; 2023 Jun; ():. PubMed ID: 37398412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metric to quantify white matter damage on brain magnetic resonance images.
    Valdés Hernández MDC; Chappell FM; Muñoz Maniega S; Dickie DA; Royle NA; Morris Z; Anblagan D; Sakka E; Armitage PA; Bastin ME; Deary IJ; Wardlaw JM
    Neuroradiology; 2017 Oct; 59(10):951-962. PubMed ID: 28815362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired oxygen extraction and adaptation of intracellular energy metabolism in cerebral small vessel disease.
    Reiländer A; Pilatus U; Schüre JR; Shrestha M; Deichmann R; Nöth U; Hattingen E; Gracien RM; Wagner M; Seiler A
    Cereb Circ Cogn Behav; 2023; 4():100162. PubMed ID: 36851996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BOLD-based cerebrovascular reactivity vascular transfer function isolates amplitude and timing responses to better characterize cerebral small vessel disease.
    Atwi S; Shao H; Crane DE; da Costa L; Aviv RI; Mikulis DJ; Black SE; MacIntosh BJ
    NMR Biomed; 2019 Mar; 32(3):e4064. PubMed ID: 30693582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease.
    Lambert C; Sam Narean J; Benjamin P; Zeestraten E; Barrick TR; Markus HS
    Neuroimage Clin; 2015; 9():194-205. PubMed ID: 26448913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between hypertension and neurovascular inflammation in both normal-appearing white matter and white matter hyperintensities.
    Solé-Guardia G; Custers E; de Lange A; Clijncke E; Geenen B; Gutierrez J; Küsters B; Claassen JAHR; de Leeuw FE; Wiesmann M; Kiliaan AJ
    Acta Neuropathol Commun; 2023 Jan; 11(1):2. PubMed ID: 36600303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
    van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
    Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT.
    Makedonov I; Black SE; MacIntosh BJ
    Eur J Neurol; 2013 Feb; 20(2):243-50. PubMed ID: 22742818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter hyperintensities and normal-appearing white matter integrity in the aging brain.
    Maniega SM; Valdés Hernández MC; Clayden JD; Royle NA; Murray C; Morris Z; Aribisala BS; Gow AJ; Starr JM; Bastin ME; Deary IJ; Wardlaw JM
    Neurobiol Aging; 2015 Feb; 36(2):909-18. PubMed ID: 25457555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study.
    van Norden AG; de Laat KF; van Dijk EJ; van Uden IW; van Oudheusden LJ; Gons RA; Norris DG; Zwiers MP; de Leeuw FE
    Biochim Biophys Acta; 2012 Mar; 1822(3):401-7. PubMed ID: 21549191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative MRI of cerebral white matter hyperintensities: A new approach towards understanding the underlying pathology.
    Iordanishvili E; Schall M; Loução R; Zimmermann M; Kotetishvili K; Shah NJ; Oros-Peusquens AM
    Neuroimage; 2019 Nov; 202():116077. PubMed ID: 31398433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous investigation of microvasculature and parenchyma in cerebral small vessel disease using intravoxel incoherent motion imaging.
    Wong SM; Zhang CE; van Bussel FC; Staals J; Jeukens CR; Hofman PA; van Oostenbrugge RJ; Backes WH; Jansen JF
    Neuroimage Clin; 2017; 14():216-221. PubMed ID: 28180080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zooming in on cerebral small vessel function in small vessel diseases with 7T MRI: Rationale and design of the "ZOOM@SVDs" study.
    van den Brink H; Kopczak A; Arts T; Onkenhout L; Siero JCW; Zwanenburg JJM; Duering M; Blair GW; Doubal FN; Stringer MS; Thrippleton MJ; Kuijf HJ; de Luca A; Hendrikse J; Wardlaw JM; Dichgans M; Biessels GJ;
    Cereb Circ Cogn Behav; 2021; 2():100013. PubMed ID: 36324717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral arterial stiffness is linked to white matter hyperintensities and perivascular spaces in older adults - A 4D flow MRI study.
    Björnfot C; Eklund A; Larsson J; Hansson W; Birnefeld J; Garpebring A; Qvarlander S; Koskinen LD; Malm J; Wåhlin A
    J Cereb Blood Flow Metab; 2024 Aug; 44(8):1343-1351. PubMed ID: 38315044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small vessel disease is associated with altered cerebrovascular pulsatility but not resting cerebral blood flow.
    Shi Y; Thrippleton MJ; Blair GW; Dickie DA; Marshall I; Hamilton I; Doubal FN; Chappell F; Wardlaw JM
    J Cereb Blood Flow Metab; 2020 Jan; 40(1):85-99. PubMed ID: 30295558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced [
    Moscoso A; Grothe MJ; Schöll M;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2283-2294. PubMed ID: 33475761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free-water diffusion MRI detects structural alterations surrounding white matter hyperintensities in the early stage of cerebral small vessel disease.
    Mayer C; Nägele FL; Petersen M; Frey BM; Hanning U; Pasternak O; Petersen E; Gerloff C; Thomalla G; Cheng B
    J Cereb Blood Flow Metab; 2022 Sep; 42(9):1707-1718. PubMed ID: 35410517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
    Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
    Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
    Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
    Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.